BAY-3827

Description: BAY-3827 is a potent and selective AMPK inhibitor with potential antitumor activity, demonstrating antiproliferative effects in an androgen-dependent prostate cancer model and inhibiting the phosphorylation of acetyl CoA carboxylase 1 (ACC-1). Target: AMPK, Acyltransferase. Smiles: C(#N)C=1C(C(C#N)=C(C)N(C)C1C)C=2C=C3C(=C(C)C2F)NN=C3NC(=O)C4=C(CC)C=CC=C4. References: Lemos C, et al. The potent AMPK inhibitor BAY-3827 shows strong efficacy in androgen-dependent prostate cancer models. Cell Oncol (Dordr). 2021 Jun,44(3):581-594.